Skip to main contentSkip to navigation
Sirius Investors
Orchard Therapeutics plc

Orchard Therapeutics plc

ORTX
NASDAQHealthcare

Revenue Analysis - ORTX

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

ORTX Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$5.6M

Collaboration

0.0% of total revenue

$743.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Collaboration
Product
Strimvelis
9/30/2023$743.0K$5.6M$0
6/30/2023$663.0K$6.7M$0
3/31/2023$703.0K$534.0K$0
12/31/2022$593.0K$6.4M$582.0K
9/30/2022$400.0K$5.4M$596.0K
6/30/2022$587.0K$3.8M$636.0K

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Collaboration+12.1%
Declining Segments
Product-16.4%

Earnings Reports

Want to see how ORTX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports